On the intrinsic disorder status of the major players in programmed cell death pathways

F1000Research

Volumn 2, Issue , 2013, Pages

  Uversky, Vladimir N ^b,d   Uversky, Alexey V ^a   Xue, Bin ^b   Peng, Zhenling ^c   Kurgan, Lukasz ^c  

^a Temple University   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d INSTITUTE FOR BIOLOGICAL INSTRUMENTATION   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

APOPTOSIS; ARTICLE; AUTOPHAGY; BINDING AFFINITY; BINDING SITE; BIOINFORMATICS; CELL ASSAY; CELL FUNCTION; CONTROLLED STUDY; INTRINSIC DISORDER; MOLECULAR DYNAMICS; NECROPTOSIS; PHYSICAL DISEASE BY BODY FUNCTION; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SCORING SYSTEM; SIGNAL TRANSDUCTION;

EID: 84907254867     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.2-190.v1     Document Type: Article

References (163)

1. Dunker AK Obradovic Z Romero P: Intrinsic protein disorder in complete genomes. Genome Inform Ser Workshop Genome Inform. 2000;11:161-171. 11700597
2. Uversky VN Dunker AK: Understanding protein non-folding. Biochim Biophys Acta. 2010;1804(6):1231-1264. 20117254 10.1016/j.bbapap.2010.01.017 2882790
3. Ward JJ Sodhi JS McGuffin LJ: Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. J Mol Biol. 2004;337(3):635-645. 15019783 10.1016/j.jmb.2004.02.002
4. Uversky VN Gillespie JR Fink AL: Why are "natively unfolded" proteins unstructured under physiologic conditions? Proteins. 2000;41(3):415-427. 11025552 10.1002/1097-0134(20001115)41:3&<415::AID-PROT130&>3.0.CO;2-7
5. Xue B Dunker AK Uversky VN: Orderly order in protein intrinsic disorder distribution: disorder in 3500 proteomes from viruses and the three domains of life. J Biomol Struct Dyn. 2012;30(2):137-149. 22702725 10.1080/07391102.2012.675145
6. Dunker AK Garner E Guilliot S: Protein disorder and the evolution of molecular recognition: theory, predictions and observations. Pac Symp Biocomput. 1998;473-484. 9697205
7. Wright PE Dyson HJ: Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J Mol Biol. 1999;293(2):321-331. 10550212 10.1006/jmbi.1999.3110
8. Dunker AK Lawson JD Brown CJ: Intrinsically disordered protein. J Mol Graph Model. 2001;19(1):26-59. 11381529 10.1016/S1093-3263(00)00138-8
9. Tompa P: Intrinsically unstructured proteins. Trends Biochem Sci. 2002;27(10):527-533. 12368089 10.1016/S0968-0004(02)02169-2
10. Daughdrill GW Pielak GJ Uversky VN: Natively disordered proteins.In: Buchner J Kiefhaber T(eds) Handbook of Protein Folding. Wiley-VCH, Verlag GmbH & Co., Weinheim, Germany,2005;pp 271-353. 10.1002/9783527619498.ch41
11. Uversky VN: Natively unfolded proteins: a point where biology waits for physics. Protein Sci. 2002;11(4):739-756. 11910019 2373528
12. Uversky VN: The mysterious unfoldome: structureless, underappreciated, yet vital part of any given proteome. J Biomed Biotechnol. 2010;2010:568068. 20011072 10.1155/2010/568068 2789583
13. Uversky VN Oldfield CJ Dunker AK: Intrinsically disordered proteins in human diseases: introducing the D2 concept. Annu Rev Biophys. 2008;37:215-246. 18573080 10.1146/annurev.biophys.37.032807.125924
14. Lee H Mok KH Muhandiram R: Local structural elements in the mostly unstructured transcriptional activation domain of human p53. J Biol Chem. 2000;275(38):29426-29432. 10884388 10.1074/jbc.M003107200
15. Adkins JN Lumb KJ: Intrinsic structural disorder and sequence features of the cell cycle inhibitor p57Kip2. Proteins. 2002;46(1):1-7. 11746698 10.1002/prot.10018
16. Chang BS Minn AJ Muchmore SW: Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2. EMBO J. 1997;16(5):968-977. 9118958 10.1093/emboj/16.5.968 1169697
17. Campbell KM Terrell AR Laybourn PJ: Intrinsic structural disorder of the C-terminal activation domain from the bZIP transcription factor Fos. Biochemistry. 2000;39(10):2708-2713. 10704222 10.1021/bi9923555
18. Sunde M McGrath KC Young L: TC-1 is a novel tumorigenic and natively disordered protein associated with thyroid cancer. Cancer Res. 2004;64(8):2766-2773. 15087392 10.1158/0008-5472.CAN-03-2093
19. Zeng Y He Y Yang F: The cancer/testis antigen prostate-associated gene 4 (PAGE4) is a highly intrinsically disordered protein. J Biol Chem. 2011;286(16):13985-13994. 21357425 10.1074/jbc.M110.210765 3077599
20. Glenner GG Wong CW: Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun. 1984;122(3):1131-1135. 6236805 10.1016/0006-291X(84)91209-9
21. Masters CL Multhaup G Simms G: Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J. 1985;4(11):2757-2763. 4065091 554575
22. Lee VM Balin BJ Otvos L Jr: A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science. 1991;251(4994):675-678. 1899488 10.1126/science.1899488
23. Ueda K Fukushima H Masliah E: Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90(23):11282-11286. 8248242 10.1073/pnas.90.23.11282 47966
24. Wisniewski KE Dalton AJ McLachlan C: Alzheimer's disease in Down's syndrome: clinicopathologic studies. Neurology. 1985;35(7):957-961. 3159974 10.1212/01.wnl.0000405415.07883.36
25. Dev KK Hofele K Barbieri S: Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease. Neuropharmacology. 2003;45(1):14-44. 12814657 10.1016/S0028-3908(03)00140-0
26. Prusiner SB: Shattuck lecture--neurodegenerative diseases and prions. N Engl J Med. 2001;344(20):1516-1526. 11357156 10.1056/NEJM200105173442006
27. Zoghbi HY Orr HT: Polyglutamine diseases: protein cleavage and aggregation. Curr Opin Neurobiol. 1999;9(5):566-570. 10508741 10.1016/S0959-4388(99)00013-6
28. Uversky VN: Amyloidogenesis of natively unfolded proteins. Curr Alzheimer Res. 2008;5(3):260-287. 18537543 10.2174/156720508784533312 2719783
29. Iakoucheva LM Brown CJ Lawson JD: Intrinsic disorder in cell-signaling and cancer-associated proteins. J Mol Biol. 2002;323(3):573-584. 12381310 10.1016/S0022-2836(02)00969-5
30. Radivojac P Iakoucheva LM Oldfield CJ: Intrinsic disorder and functional proteomics. Biophys J. 2007;92(5):1439-1456. 17158572 10.1529/biophysj.106.094045 1796814
31. Cheng Y LeGall T Oldfield CJ: Abundance of intrinsic disorder in protein associated with cardiovascular disease. Biochemistry. 2006;45(35):10448-10460. 16939197 10.1021/bi060981d
32. Uversky VN Oldfield CJ Midic U: Unfoldomics of human diseases: linking protein intrinsic disorder with diseases. BMC Genomics. 2009;10(Suppl 1):S7. 19594884 10.1186/1471-2164-10-S1-S7 2709268
33. Uversky VN: Intrinsic disorder in proteins associated with neurodegenerative diseases. Front Biosci (Landmark Ed). 2009;14:5188-5238. 19482612 10.2741/3594
34. Mohan A Sullivan WJ Jr Radivojac P: Intrinsic disorder in pathogenic and non-pathogenic microbes: discovering and analyzing the unfoldomes of early-branching eukaryotes. Mol Biosyst. 2008;4(4):328-340. 18354786 10.1039/b719168e
35. Midic U Oldfield CJ Dunker AK: Protein disorder in the human diseasome: Unfoldomics of human genetic diseases. BMC Genomics. 2009;10(Suppl 1):S12. 19594871 10.1186/1471-2164-10-S1-S12 2709255
36. Rajagopalan K Mooney SM Parekh N: A majority of the cancer/testis antigens are intrinsically disordered proteins. J Cell Biochem. 2011;112(11):3256-3267. 21748782 10.1002/jcb.23252 3214731
37. Dunker AK Cortese MS Romero P: Flexible nets: The roles of intrinsic disorder in protein interaction networks. FEBS J. 2005;272(20):5129-5148. 16218947 10.1111/j.1742-4658.2005.04948.x
38. Oldfield CJ Cheng Y Cortese MS: Comparing and combining predictors of mostly disordered proteins. Biochemistry. 2005;44(6):1989-2000. 15697224 10.1021/bi047993o
39. Vucetic S Xie H Iakoucheva LM: Functional anthology of intrinsic disorder. 2. Cellular components, domains, technical terms, developmental processes, and coding sequence diversities correlated with long disordered regions. J Proteome Res. 2007;6(5):1899-1916. 17391015 10.1021/pr060393m 2588346
40. Xie H Vucetic S Iakoucheva LM: Functional anthology of intrinsic disorder. 1. Biological processes and functions of proteins with long disordered regions. J Proteome Res. 2007;6(5):1882-1898. 17391014 10.1021/pr060392u 2543138
41. Xie H Vucetic S Iakoucheva LM: Functional anthology of intrinsic disorder. 3. Ligands, post-translational modifications, and diseases associated with intrinsically disordered proteins. J Proteome Res. 2007;6(5):1917-1932. 17391016 10.1021/pr060394e 2588348
42. Peng Z Xue B Kurgan L: Resilience of death: intrinsic disorder in proteins involved in the programmed cell death. Cell Death Differ. 2013;20(9):1257-1267. 23764774 10.1038/cdd.2013.65 3741502
43. Kaczmarek A Vandenabeele P Krysko DV: Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity. 2013;38(2):209-223. 23438821 10.1016/j.immuni.2013.02.003
44. Eisenberg-Lerner A Bialik S Simon HU: Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ. 2009;16(7):966-975. 19325568 10.1038/cdd.2009.33
45. He C Klionsky DJ: Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet. 2009;43:67-93. 19653858 10.1146/annurev-genet-102808-114910 2831538
46. Liu B Cheng Y Liu Q: Autophagic pathways as new targets for cancer drug development. Acta Pharmacol Sin. 2010;31(9):1154-1164. 20694022 10.1038/aps.2010.118 3587337
47. Bialik S Zalckvar E Ber Y: Systems biology analysis of programmed cell death. Trends Biochem Sci. 2010;35(10):556-564. 20537543 10.1016/j.tibs.2010.04.008
48. Galluzzi L Vanden Berghe T Vanlangenakker N: Programmed necrosis from molecules to health and disease. Int Rev Cell Mol Biol. 2011;289:1-35. 21749897 10.1016/B978-0-12-386039-2.00001-8
49. Ouyang L Shi Z Zhao S: Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif. 2012;45(6):487-498. 23030059 10.1111/j.1365-2184.2012.00845.x
50. Tan ML Ooi JP Ismail N: Programmed cell death pathways and current antitumor targets. Pharm Res. 2009;26(7):1547-1560. 19407932 10.1007/s11095-009-9895-1
51. Xie Z Klionsky DJ: Autophagosome formation: core machinery and adaptations. Nat Cell Biol. 2007;9(10):1102-1109. 17909521 10.1038/ncb1007-1102
52. Huett A Goel G Xavier RJ: A systems biology viewpoint on autophagy in health and disease. Curr Opin Gastroenterol. 2010;26(4):302-309. 20571384 10.1097/MOG.0b013e32833ae2ed
53. Chen S Rehman SK Zhang W: Autophagy is a therapeutic target in anticancer drug resistance. Biochim Biophys Acta. 2010;1806(2):220-229. 20637264 10.1016/j.bbcan.2010.07.003
54. Li ZY Yang Y Ming M: Mitochondrial ROS generation for regulation of autophagic pathways in cancer. Biochem Biophys Res Commun. 2011;414(1):5-8. 21951851 10.1016/j.bbrc.2011.09.046
55. Liu JJ Lin M Yu JY: Targeting apoptotic and autophagic pathways for cancer therapeutics. Cancer Lett. 2011;300(2):105-114. 21036469 10.1016/j.canlet.2010.10.001
56. Henriquez M Armisen R Stutzin A: Cell death by necrosis, a regulated way to go. Curr Mol Med. 2008;8(3):187-206. 18473819 10.2174/156652408784221289
57. Cohen GM: Caspases: the executioners of apoptosis. Biochem J. 1997;326(Pt 1):1-16. 9337844 1218630
58. Brune B: Nitric oxide: NO apoptosis or turning it ON? Cell Death Differ. 2003;10(8):864-869. 12867993 10.1038/sj.cdd.4401261
59. Brune B Zhou J von Knethen A: Nitric oxide, oxidative stress, and apoptosis. Kidney Int. 2003;63(Suppl 84):S22-24. 12694301 10.1046/j.1523-1755.63.s84.6.x
60. Brune B Schneiderhan N: Nitric oxide evoked p53-accumulation and apoptosis. Toxicol Lett. 2003;139(2-3):119-123. 12628747 10.1016/S0378-4274(02)00426-5
61. Popov SG Villasmil R Bernardi J: Lethal toxin of Bacillus anthracis causes apoptosis of macrophages. Biochem Biophys Res Commun. 2002;293(1):349-355. 12054607 10.1016/S0006-291X(02)00227-9
62. Fridman JS Lowe SW: Control of apoptosis by p53. Oncogene. 2003;22(56):9030-9040. 14663481 10.1038/sj.onc.1207116
63. Peter ME Krammer PH: The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 2003;10(1):26-35. 12655293 10.1038/sj.cdd.4401186
64. Mattson MP Chan SL: Calcium orchestrates apoptosis. Nat Cell Biol. 2003;5(12):1041-1043. 14647298 10.1038/ncb1203-1041
65. Kroemer G Reed JC: Mitochondrial control of cell death. Nat Med. 2000;6(5):513-519. 10802706 10.1038/74994
66. Reed JC Kroemer G: Mechanisms of mitochondrial membrane permeabilization. Cell Death Differ. 2000;7(12):1145. 11175250 10.1038/sj.cdd.4400777
67. Widlak P Li LY Wang X: Action of recombinant human apoptotic endonuclease G on naked DNA and chromatin substrates: cooperation with exonuclease and DNase I. J Biol Chem. 2001;276(51):48404-48409. 11606588 10.1074/jbc.M108461200
68. Li LY Luo X Wang X: Endonuclease G is an apoptotic DNase when released from mitochondria. Nature. 2001;412(6842):95-99. 11452314 10.1038/35083620
69. Parrish J Li L Klotz K: Mitochondrial endonuclease G is important for apoptosis in C. elegans. Nature. 2001;412(6842):90-94. 11452313 10.1038/35083608
70. Tsujimoto Y: Cell death regulation by the Bcl-2 protein family in the mitochondria. J Cell Physiol. 2003;195(2):158-167. 12652643 10.1002/jcp.10254
71. Degterev A Huang Z Boyce M: Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol. 2005;1(2):112-119. 16408008 10.1038/nchembio711
72. Festjens N Vanden Berghe T Vandenabeele P: Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response. Biochim Biophys Acta. 2006;1757(9-10):1371-1387. 16950166 10.1016/j.bbabio.2006.06.014
73. Boujrad H Gubkina O Robert N: AIF-mediated programmed necrosis: a highly regulated way to die. Cell Cycle. 2007;6(21):2612-2619. 17912035
74. Eisenberg-Lerner A Kimchi A: DAP kinase regulates JNK signaling by binding and activating protein kinase D under oxidative stress. Cell Death Differ. 2007;14(11):1908-1915. 17703233 10.1038/sj.cdd.4402212
75. Morgan MJ Kim YS Liu ZG: TNFalpha and reactive oxygen species in necrotic cell death. Cell Res. 2008;18(3):343-349. 18301379 10.1038/cr.2008.31
76. Diez J Walter D Munoz-Pinedo C: DeathBase: a database on structure, evolution and function of proteins involved in apoptosis and other forms of cell death. Cell Death Differ. 2010;17(5):735-736. 20383157 10.1038/cdd.2009.215
77. Xue B Dunbrack RL Williams RW: PONDR-FIT: a meta-predictor of intrinsically disordered amino acids. Biochim Biophys Acta. 2010;1804(4):996-1010. 20100603 10.1016/j.bbapap.2010.01.011 2882806
78. Romero P Obradovic Z Li X: Sequence complexity of disordered protein. Proteins. 2001;42(1):38-48. 11093259 10.1002/1097-0134(20010101)42:1&<38::AID-PROT50&>3.0.CO;2-3
79. Peng K Vucetic S Radivojac P: Optimizing long intrinsic disorder predictors with protein evolutionary information. J Bioinform Comput Biol. 2005;3(1):35-60. 15751111 10.1142/S0219720005000886
80. Peng K Radivojac P Vucetic S: Length-dependent prediction of protein intrinsic disorder. BMC Bioinformatics. 2006;7:208. 16618368 10.1186/1471-2105-7-208 1479845
81. Prilusky J Felder CE Zeev-Ben-Mordehai T: FoldIndex: a simple tool to predict whether a given protein sequence is intrinsically unfolded. Bioinformatics. 2005;21(16):3435-3438. 15955783 10.1093/bioinformatics/bti537
82. Dosztanyi Z Csizmok V Tompa P: IUPred: web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content. Bioinformatics. 2005;21(16):3433-3434. 15955779 10.1093/bioinformatics/bti541
83. Campen A Williams RM Brown CJ: TOP-IDP-scale: a new amino acid scale measuring propensity for intrinsic disorder. Protein Pept Lett. 2008;15(9):956-963. 18991772 10.2174/092986608785849164 2676888
84. Oldfield CJ Cheng Y Cortese MS: Coupled folding and binding with alpha-helix-forming molecular recognition elements. Biochemistry. 2005;44(37):12454-12470. 16156658 10.1021/bi050736e
85. Cheng Y Oldfield CJ Meng J: Mining alpha-helix-forming molecular recognition features with cross species sequence alignments. Biochemistry. 2007;46(47):13468-13477. 17973494 10.1021/bi7012273 2570644
86. Meszaros B Simon I Dosztanyi Z: Prediction of protein binding regions in disordered proteins. PLoS Comput Biol. 2009;5(5):e1000376. 19412530 10.1371/journal.pcbi.1000376 2671142
87. Dosztanyi Z Meszaros B Simon I: ANCHOR: web server for predicting protein binding regions in disordered proteins. Bioinformatics. 2009;25(20):2745-2746. 19717576 10.1093/bioinformatics/btp518 2759549
88. Dosztanyi Z Csizmok V Tompa P: The pairwise energy content estimated from amino acid composition discriminates between folded and intrinsically unstructured proteins. J Mol Biol. 2005;347(4):827-839. 15769473 10.1016/j.jmb.2005.01.071
89. Peng Z Mizianty MJ Xue B: More than just tails: intrinsic disorder in histone proteins. Mol Biosyst. 2012;8(7):1886-1901. 22543956 10.1039/c2mb25102g
90. Kirilyuk A Shimoji M Catania J: An intrinsically disordered region of the acetyltransferase p300 with similarity to prion-like domains plays a role in aggregation. Plos One. 2012;7(11):e48243. 23133622 10.1371/journal.pone.0048243 3486812
91. Coelho Ribeiro Mde L Espinosa J Islam S: Malleable ribonucleoprotein machine: protein intrinsic disorder in the Saccharomyces cerevisiae spliceosome. PeerJ. 2013;1:e2. 23638354 10.7717/peerj.2 3628832
92. Szklarczyk D Franceschini A Kuhn M: The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 2011;39(Database issue):D561-568. 21045058 10.1093/nar/gkq973 3013807
93. Peter ME Krammer PH: Mechanisms of CD95(APO-1/Fas)-mediated apoptosis. Curr Opin Immunol. 1998;10(5):545-551. 9794832 10.1016/S0952-7915(98)80222-7
94. Green DR Reed JC: Mitochondria and apoptosis. Science. 1998;281(5381):1309-1312. 9721092 10.1126/science.281.5381.1309
95. Green D Kroemer G: The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol. 1998;8(7):267-271. 9714597 10.1016/S0962-8924(98)01273-2
96. Yin XM: Signal transduction mediated by Bid, a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathways. Cell Res. 2000;10(3):161-167. 11032168 10.1038/sj.cr.7290045
97. Martinon F Holler N Richard C: Activation of a pro-apoptotic amplification loop through inhibition of NF-kappaB-dependent survival signals by caspase-mediated inactivation of RIP. FEBS Lett. 2000;468(2-3):134-136. 10692573 10.1016/S0014-5793(00)01212-6
98. Holler N Zaru R Micheau O: Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol. 2000;1(6):489-495. 11101870 10.1038/82732
99. Declercq W Vanden Berghe T Vandenabeele P: RIP kinases at the crossroads of cell death and survival. Cell. 2009;138(2):229-232. 19632174 10.1016/j.cell.2009.07.006
100. Degterev A Hitomi J Germscheid M: Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol. 2008;4(5):313-321. 18408713 10.1038/nchembio.83
101. Eisenberg T Carmona-Gutierrez D Büttner S: Necrosis in yeast. Apoptosis. 2010;15(3):257-268. 20069456 10.1007/s10495-009-0453-4
102. Scaffidi P Misteli T Bianchi ME: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002;418(6894):191-195. 12110890 10.1038/nature00858
103. Zhao R Gish K Murphy M: Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev. 2000;14(8):981-993. 10783169 10.1101/gad.14.8.981 316542
104. Balint EE Vousden KH: Activation and activities of the p53 tumour suppressor protein. Br J Cancer. 2001;85(12):1813-1823. 11747320 10.1054/bjoc.2001.2128 2364002
105. el-Deiry WS: Regulation of p53 downstream genes. Semin Cancer Biol. 1998;8(5):345-357. 10101800 10.1006/scbi.1998.0097
106. Yu J Zhang L Hwang PM: Identification and classification of p53-regulated genes. Proc Natl Acad Sci U S A. 1999;96(25):14517-14522. 10588737 10.1073/pnas.96.25.14517 24468
107. Sax JK El-Deiry WS: p53-induced gene expression analysis. Methods Mol Biol. 2003;234:65-71. 12824525 10.1385/1-59259-408-5:65
108. Anderson CW Appella E: Signaling to the p53 tumor suppressor through pathways activated by genotoxic and nongenotoxic stress.In: Bradshaw RA Dennis EA (eds) Handbook of Cell Signaling. Academic Press, New York,2004;pp 237-247.
109. Gottlieb TM Leal JF Seger R: Cross-talk between Aktp 53 and Mdm2: possible implications for the regulation of apoptosis. Oncogene. 2002;21(8):1299-1303. 11850850 10.1038/sj/onc/1205181
110. Nicholson KM Anderson NG: The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal. 2002;14(5):381-395. 11882383 10.1016/S0898-6568(01)00271-6
111. Collins MK Perkins GR Rodriguez-Tarduchy G: Growth factors as survival factors: regulation of apoptosis. Bioessays. 1994;16(2):133-138. 8147843 10.1002/bies.950160210
112. Malaney P Pathak RR Xue B: Intrinsic Disorder in PTEN and its Interactome Confers Structural Plasticity and Functional Versatility. Sci Rep. 2013;3:2035. 23783762 10.1038/srep02035 3687229
113. Shieh SY Ahn J Tamai K: The human homologs of checkpoint kinases Chk1 and Cds1(Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 2000;14(3):289-300. 10673501 10.1101/gad.14.3.289 316358
114. Chen L Gilkes DM Pan Y: ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage. EMBO J. 2005;24(19):3411-3422. 16163388 10.1038/sj.emboj.7600812 1276172
115. Miyashita T Krajewski S Krajewska M: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 1994;9(6):1799-1805. 8183579
116. Nakano K Vousden KH: PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell. 2001;7(3):683-694. 11463392 10.1016/S1097-2765(01)00214-3
117. Oda E Ohki R Murasawa H: Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science. 2000;288(5468):1053-1058. 10807576 10.1126/science.288.5468.1053
118. Sax JK Fei P Murphy ME: BID regulation by p53 contributes to chemosensitivity. Nat Cell Biol. 2002;4(11):842-849. 12402042 10.1038/ncb866
119. Oda K Arakawa H Tanaka T: p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell. 2000;102(6):849-862. 11030628 10.1016/S0092-8674(00)00073-8
120. Meley D Spiller DG White MR: p53-mediated delayed NF-kappaB activity enhances etoposide-induced cell death in medulloblastoma. Cell Death Dis. 2010;1:e41. 21364648 10.1038/cddis.2010.16 3032310
121. Sharp AN Heazell AE Crocker IP: Placental apoptosis in health and disease. Am J Reprod Immunol. 2010;64(3):159-169. 20367628 10.1111/j.1600-0897.2010.00837.x 3025811
122. Amaral JD Castro RE Steer CJ: p53 and the regulation of hepatocyte apoptosis: implications for disease pathogenesis. Trends Mol Med. 2009;15(11):531-541. 19822456 10.1016/j.molmed.2009.09.005
123. Davies L Spiller D White MR: PERP expression stabilizes active p53 via modulation of p53-MDM2 interaction in uveal melanoma cells. Cell Death Dis. 2011;2:e136. 21451571 10.1038/cddis.2011.19 3101815
124. Uversky VN Oldfield CJ Dunker AK: Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling. J Mol Recognit. 2005;18(5):343-384. 16094605 10.1002/jmr.747
125. Bustos DM Iglesias AA: Intrinsic disorder is a key characteristic in partners that bind 14-3-3 proteins. Proteins. 2006;63(1):35-42. 16444738 10.1002/prot.20888
126. Radivojac P Vucetic S O'Connor TR: Calmodulin signaling: analysis and prediction of a disorder-dependent molecular recognition. Proteins. 2006;63(2):398-410. 16493654 10.1002/prot.20873
127. Patil A Nakamura H: Disordered domains and high surface charge confer hubs with the ability to interact with multiple proteins in interaction networks. FEBS Lett. 2006;580(8):2041-2045. 16542654 10.1016/j.febslet.2006.03.003
128. Ekman D Light S Bjorklund AK: What properties characterize the hub proteins of the protein-protein interaction network of Saccharomyces cerevisiae? Genome Biol. 2006;7(6):R45. 16780599 10.1186/gb-2006-7-6-r45 1779539
129. Haynes C Oldfield CJ Ji F: Intrinsic disorder is a common feature of hub proteins from four eukaryotic interactomes. PLoS Comput Biol. 2006;2(8):e100. 16884331 10.1371/journal.pcbi.0020100 1526461
130. Dosztanyi Z Chen J Dunker AK: Disorder and sequence repeats in hub proteins and their implications for network evolution. J Proteome Res. 2006;5(11):2985-2995. 17081050 10.1021/pr060171o
131. Singh GP Dash D: Intrinsic disorder in yeast transcriptional regulatory network. Proteins. 2007;68(3):602-605. 17510967 10.1002/prot.21497
132. Singh GP Ganapathi M Dash D: Role of intrinsic disorder in transient interactions of hub proteins. Proteins. 2007;66(4):761-765. 17154416 10.1002/prot.21281
133. Berman HM Westbrook J Feng Z: The Protein Data Bank. Nucleic Acids Res. 2000;28(1):235-242. 10592235 10.1093/nar/28.1.235 102472
134. Uversky VN Dunker AK: Understanding protein non-folding. Biochim Biophys Acta. 2010;1804(6):1231-1264. 20117254 10.1016/j.bbapap.2010.01.017 2882790
135. Dunker AK Brown CJ Lawson JD: Intrinsic disorder and protein function. Biochemistry. 2002;41(21):6573-6582. 12022860
136. Dunker AK Brown CJ Obradovic Z: Identification and functions of usefully disordered proteins. Adv Protein Chem. 2002;62:25-49. 12418100
137. Tompa P: Intrinsically unstructured proteins. Trends Biochem Sci. 2002;27(10):527-533. 12368089 10.1016/S0968-0004(02)02169-2
138. Uversky VN Oldfield CJ Dunker AK: Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling. J Mol Recognit. 2005;18(5):343-384. 16094605 10.1002/jmr.747
139. Dunker AK Silman I Uversky VN: Function and structure of inherently disordered proteins. Curr Opin Struct Biol. 2008;18(6):756-764. 18952168 10.1016/j.sbi.2008.10.002
140. Dunker AK Uversky VN: Signal transduction via unstructured protein conduits. Nat Chem Biol. 2008;4(4):229-230. 18347590 10.1038/nchembio0408-229
141. Uversky VN: Multitude of binding modes attainable by intrinsically disordered proteins: a portrait gallery of disorder-based complexes. Chem Soc Rev. 2011;40(3):1623-1634. 21049125 10.1039/c0cs00057d
142. Uversky VN: Disordered competitive recruiter: fast and foldable. J Mol Biol. 2012;418(5):267-268. 22381408 10.1016/j.jmb.2012.02.034
143. Uversky VN: Intrinsic Disorder-based Protein Interactions and their Modulators. Curr Pharm Des. 2013;19(23):4191-4213. 23170892 10.2174/1381612811319230005
144. Dyson HJ Wright PE: Coupling of folding and binding for unstructured proteins. Curr Opin Struct Biol. 2002;12(1):54-60. 11839490 10.1016/S0959-440X(02)00289-0
145. Dyson HJ Wright PE: Intrinsically unstructured proteins and their functions. Nat Rev Mol Cell Biol. 2005;6(3):197-208. 15738986 10.1038/nrm1589
146. Wright PE Dyson HJ: Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J Mol Biol. 1999;293(2):321-331. 10550212 10.1006/jmbi.1999.3110
147. Mohan A Oldfield CJ Radivojac P: Analysis of molecular recognition features (MoRFs). J Mol Biol. 2006;362(5):1043-1059. 16935303 10.1016/j.jmb.2006.07.087
148. Vacic V Oldfield CJ Mohan A: Characterization of molecular recognition features, MoRFs, and their binding partners. J Proteome Res. 2007;6(6):2351-2366. 17488107 10.1021/pr0701411 2570643
149. Uversky VN: Unusual biophysics of intrinsically disordered proteins. Biochim Biophys Acta. 2013;1834(5):932-951. 23269364 10.1016/j.bbapap.2012.12.008
150. Van Herreweghe F Festjens N Declercq W: Tumor necrosis factor-mediated cell death: to break or to burst, that's the question. Cell Mol Life Sci. 2010;67(10):1567-1579. 20198502 10.1007/s00018-010-0283-0
151. Meulmeester E Jochemsen AG: p53: A guide to apoptosis. Curr Cancer Drug Targets. 2008;8(2):87-97. 18336191 10.2174/156800908783769337
152. Zhivotovsky B Kroemer G: Apoptosis and genomic instability. Nat Rev Mol Cell Biol. 2004;5(9):752-762. 15340382 10.1038/nrm1443
153. Chen H Ma J Li W: A molecular brake in the kinase hinge region regulates the activity of receptor tyrosine kinases. Mol Cell. 2007;27(5):717-730. 17803937 10.1016/j.molcel.2007.06.028 2094128
154. Sheng Y Saridakis V Sarkari F: Molecular recognition of p53 and MDM2 by USP7/HAUSP. Nat Struct Mol Biol. 2006;13(3):285-291. 16474402 10.1038/nsmb1067
155. Rustandi RR Baldisseri DM Weber DJ: Structure of the negative regulatory domain of p53 bound to S100B(betabeta). Nat Struct Biol. 2000;7(7):570-574. 10876243 10.1038/76797
156. Mittl PR Chene P Grutter MG: Crystallization and structure solution of p53 (residues 326-356) by molecular replacement using an NMR model as template. Acta Crystallogr D Biol Crystallogr. 1998;54(Pt 1):86-89. 9761820 10.1107/S0907444997006550
157. Kussie PH Gorina S Marechal V: Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science. 1996;274(5289):948-953. 8875929 10.1126/science.274.5289.948
158. Bochkareva E Kaustov L Ayed A: Single-stranded DNA mimicry in the p53 transactivation domain interaction with replication protein A. Proc Natl Acad Sci U S A. 2005;102(43):15412-15417. 16234232 10.1073/pnas.0504614102 1266094
159. Feng H Jenkins LM Durell SR: Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation. Structure. 2009;17(2):202-210. 19217391 10.1016/j.str.2008.12.009 2705179
160. Wu HH Wu PY Huang KF: Structural delineation of MDC1-FHA domain binding with CHK2-pThr68. Biochemistry. 2012;51(2):575-577. 22211259 10.1021/bi201709w
161. Czabotar PE Westphal D Dewson G: Bax crystal structures reveal how BH3 domains activate Bax and nucleate its oligomerization to induce apoptosis. Cell. 2013;152(3):519-531. 23374347 10.1016/j.cell.2012.12.031
162. Peyerl FW Dai S Murphy GA: Elucidation of some Bax conformational changes through crystallization of an antibody-peptide complex. Cell Death Differ. 2007;14(3):447-452. 16946732 10.1038/sj.cdd.4402025
163. Czabotar PE Lee EF Thompson GV: Mutation to Bax beyond the BH3 domain disrupts interactions with pro-survival proteins and promotes apoptosis. J Biol Chem. 2011;286(9):7123-7131. 21199865 10.1074/jbc.M110.161281 3044969